Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1094 Articles

Trey Thoelcke | Oct 21, 2016 at 7:45 AM EDT

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even…

Jon C. Ogg | Oct 19, 2016 at 10:35 AM EDT

5 Dow Stocks Outperforming Analyst Expectations for 2016

Of the 30 Dow Jones Industrial Average stocks, only five of them have outperformed analyst expectations this year, though some…

Chris Lange | Oct 18, 2016 at 9:15 AM EDT

Johnson & Johnson Remains Flat Despite Earnings Beat

Johnson & Johnson released a better-than-expected third-quarter report before the markets opened on Tuesday.

Chris Lange | Oct 17, 2016 at 12:15 PM EDT

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson is expected to release its most recent earnings report before the markets open on Tuesday.

Chris Lange | Oct 16, 2016 at 10:20 AM EDT

Top DJIA Earnings Reports in the Week Ahead

A third of the Dow Jones Industrial Average is reporting quarterly results this week, which has the potential to push…

Jon C. Ogg | Oct 3, 2016 at 10:50 AM EDT

4 DJIA Stocks That Have Raised Dividends for Over 50 Years Straight

Here are four Dow stocks that have raised their dividends for 50 years or more, and that also appear to…

Jon C. Ogg | Sep 28, 2016 at 11:50 AM EDT

7 Giant Companies Raising Their Dividends for 25 Years or More

These corporate giants have stated or admitted on their own that they are in the 25-year dividend hike game.

Jon C. Ogg | Sep 26, 2016 at 10:50 AM EDT

New Crohn’s Disease Drug Approved by FDA

A unit of Johnson & Johnson has announced that the FDA has approved its Stelara for the treatment of moderately…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Chris Lange | Sep 2, 2016 at 7:40 AM EDT

8 Major FDA Decisions and Trial Results to Watch for in September

24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.

Paul Ausick | Aug 22, 2016 at 4:01 PM EDT

Apple, J&J Weigh on DJIA Monday

August 22, 2016: Markets opened lower again Monday as investors remain cautious ahead of the Fed’s Jackson Hole conference beginning…

Jon C. Ogg | Jul 20, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Johnson & Johnson, Lockheed Martin, MGIC Investment, TransCanada, Verizon and More

The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Johnson & Johnson, Lockheed Martin, MGIC Investment, TransCanada…

Paul Ausick | Jul 19, 2016 at 4:01 PM EDT

McDonald’s, J&J Buoy DJIA on Tuesday

July 19, 2016: Markets opened mixed on Tuesday with the blue chips opening lower before bouncing higher. Unlike the S&P…

Chris Lange | Jul 19, 2016 at 9:25 AM EDT

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

As one of the largest health care companies on the market, Johnson & Johnson helps set a direction for the…

Chris Lange | Jul 18, 2016 at 10:25 AM EDT

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson is set to release its second-quarter earnings report before the markets open on Tuesday, a period in…

1 … 31 32 33 34 35 … 73

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

5 Dow Stocks Outperforming Analyst Expectations for 2016

Johnson & Johnson Remains Flat Despite Earnings Beat

What to Look for in Johnson & Johnson Earnings

Top DJIA Earnings Reports in the Week Ahead

4 DJIA Stocks That Have Raised Dividends for Over 50 Years Straight

7 Giant Companies Raising Their Dividends for 25 Years or More

New Crohn’s Disease Drug Approved by FDA

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

8 Major FDA Decisions and Trial Results to Watch for in September

Apple, J&J Weigh on DJIA Monday

Top Analyst Upgrades and Downgrades: Johnson & Johnson, Lockheed Martin, MGIC Investment, TransCanada, Verizon and More

McDonald’s, J&J Buoy DJIA on Tuesday

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

What to Look for in Johnson & Johnson Earnings

The $700 Billion Spending Cycle That Will Define AIQ’s Next 12 Months

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

The $700 Billion Spending Cycle That Will Define AIQ’s Next 12 Months

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

5 Dow Stocks Outperforming Analyst Expectations for 2016

Johnson & Johnson Remains Flat Despite Earnings Beat

What to Look for in Johnson & Johnson Earnings

Top DJIA Earnings Reports in the Week Ahead

4 DJIA Stocks That Have Raised Dividends for Over 50 Years Straight

7 Giant Companies Raising Their Dividends for 25 Years or More

New Crohn’s Disease Drug Approved by FDA

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

8 Major FDA Decisions and Trial Results to Watch for in September

Apple, J&J Weigh on DJIA Monday

Top Analyst Upgrades and Downgrades: Johnson & Johnson, Lockheed Martin, MGIC Investment, TransCanada, Verizon and More

McDonald’s, J&J Buoy DJIA on Tuesday

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

What to Look for in Johnson & Johnson Earnings

The $700 Billion Spending Cycle That Will Define AIQ’s Next 12 Months

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Featured Reads

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month